Participant flow12

How many started, completed or left each group, period by period.

1 to 12 of 12

Period	Milestone	Group	Participants
Overall Study	STARTED	Tofacitinib	3,681
Overall Study	STARTED	TNFi	11,667
Overall Study	STARTED	Abatacept	3,528
Overall Study	STARTED	IL-6	2,464
Overall Study	COMPLETED	Tofacitinib	3,681
Overall Study	COMPLETED	TNFi	11,667
Overall Study	COMPLETED	Abatacept	3,528
Overall Study	COMPLETED	IL-6	2,464
Overall Study	NOT COMPLETED	Tofacitinib	0
Overall Study	NOT COMPLETED	TNFi	0
Overall Study	NOT COMPLETED	Abatacept	0
Overall Study	NOT COMPLETED	IL-6	0

Source ClinicalTrials.govtrials-2026-11-12-0.5.0

Sources 3

ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
ClinicalTrials.govNo license stated
NIH RePORTER's clinical studies and project filesPublic domain

Each source's terms

ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
ClinicalTrials.govnone stated
NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Twenty rows a page, as JSON. No key.

GET https://conductscience.org/api/trials/v1/NCT06418529/flow